Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis
Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Scientifically Unexciting: Commercially Irrelevant & Futile
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(58)
•••
Comment by SamV21on Oct 18, 2021 9:34pm
94 Views
Post# 34020662

RE:RE:RE:RE:Scientifically Unexciting: Commercially Irrelevant & Futile

RE:RE:RE:RE:Scientifically Unexciting: Commercially Irrelevant & FutileNo can not believe how out of touch with reality you are , are you going to buy my shares or shut up and stop making things up and scamming people , you are a pumper , thats all you are .You dared everyone to short at .28 cents, you said the price was going to .60 when it was .50 , you said we were going to a dollar by the end of the month in the last pump and dump we had .You have nothing , no new science , no DIN, no lab , no office and now no more research on Qixleef if the research company can not secure another bank loan.Banks just don't close accounts for no reason , I am sure there was plenty of notices and warnings , get real .Pumpers don't seem to care about the truth or details , they pump and cheer and scam , name call if called out and just repeat the junk promo posted on Tetras web page which they don't read or understand themselves.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities